Life Sciences
The company will use the funds to drive adoption of its platform and provide capital infusion for expansion in the health markets.
The combined platforms will target emergency room overcrowding and emergency medical services staffing shortages.
The monitor aims to simplify clinical workflows, automate patient engagement and allow for patient-reported outcomes collection.
Industry leaders weigh in on notable topics that affected healthcare from data security to health system consolidation.
Industry executives share their thoughts on the year's digital health developments - from an increased focus on women’s health to the rise of generative AI.
The merger aims to allow for matching ideal patients with clinical studies at a faster rate, streamline research and lower costs.
The company will use the funds to enhance its R&D strategy, advance its SEEDIT platform and boost product development.
The aim is to provide AI-powered cancer risk prediction and independent report generation to help clinicians detect cancer.
The deal boosts GE HealthCare's pharma diagnostics sector and signifies its dedication to molecular imaging.
The aim is to provide long-term behavioral change focusing on weight loss and maintenance.